ZURICH/FRANKFURT (Reuters) - Shares in Actelion Ltd jumped as much as 19 percent to record highs on Friday on reports that U.S. healthcare company Johnson & Johnson was interested in a takeover of the fast-growing Swiss biotechnology firm.